Targeted degradation of c-Myc through the midnolin–proteasome pathway
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2520128123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Jingyuan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Center, Central Hospital of Dalian University of Technology, Dalian 116011, China. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-myc, Proteolysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Targeted protein degradation (TPD) has emerged as a promising therapeutic strategy; however, most TPD technologies employ either the ubiquitin–proteasome system or the lysosomal degradation system. Here, we report the development of midnolin-based targeting chimeras (MbTACs), a ubiquitin-independent TPD that degrades target proteins. We designed and synthesized peptide-based MbTACs, which are multifunctional molecules containing c-Myc-recognition moieties and midnolin binding moieties. MbTACs promote the formation of a ternary complex consisting of the target protein, MbTACs, and midnolin via chemically induced proximity; subsequently, midnolin recruits the proteasome to degrade the target protein. Biological evaluations demonstrated that the MbTACs could degrade c-Myc effectively through the midnolin–proteasome pathway. The antitumor effects of MbTACs were further validated in vitro and in vivo. Collectively, our results provide a ubiquitin-independent TPD tool. MbTACs represent a conveniently developed modular peptide degradation chimera and have the potential to be widely used in disease therapy. We expect the MbTACs to provide a dimension for TPD design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Center, Central Hospital of Dalian University of Technology, Dalian 116011, China.
- Laboratory Medicine College of Dalian Medical University, Dalian 116044, China.
- The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
ORCID-Profile: Jingyuan Zhao, Huanhuan Wu, Han Yu, Chenyu Li, Yuling Mao, Hong Yuan, Shuai Li
Zitieren
APA
Zhao, J., Wu, H., Yu, H., Li, C., Mao, Y., Yuan, H., & Li, S. (2026). Targeted degradation of c-Myc through the midnolin–proteasome pathway. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2520128123
Vancouver
Zhao J, Wu H, Yu H, Li C, Mao Y, Yuan H, et al. Targeted degradation of c-Myc through the midnolin–proteasome pathway. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2520128123
BibTeX
@article{Zhao2026,
author = {Zhao, Jingyuan and Wu, Huanhuan and Yu, Han and Li, Chenyu and Mao, Yuling and Yuan, Hong and Li, Shuai},
title = {Targeted degradation of c-Myc through the midnolin–proteasome pathway},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2520128123}
}
EUVIMED